Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “CTX”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT00281983
What this trial is testing

Fludarabine and Cyclophosphamide in Treating Patients Who Are Undergoing Donor Stem Cell Transplant for Chronic Lymphocytic Leukemia or Waldenstrom's Macroglobulinemia

Who this might be right for
Chronic Lymphocytic Leukemia
German CLL Study Group 100
Testing effectiveness (Phase 2)Active Not RecruitingNCT04904588
What this trial is testing

HLA-Mismatched Unrelated Donor Hematopoietic Cell Transplantation With Post-Transplantation Cyclophosphamide

Who this might be right for
Acute Lymphoblastic LeukemiaAcute Myelogenous LeukemiaMixed Phenotype Acute Leukemia+5 more
Center for International Blood and Marrow Transplant Research 300
Very early researchLooking for participantsNCT06142396
What this trial is testing

Pilot Study Dara-CyBorD in Newly Diagnosed Multiple Myeloma Patients With Renal Failure

Who this might be right for
Multiple MyelomaRenal Failure
Augusta University 30
Not applicableStudy completedNCT02638220
What this trial is testing

Cerebrotendinous Xanthomatosis (CTX) Prevalence Study

Who this might be right for
Cerebrotendinous Xanthomatosis (CTX)
Travere Therapeutics, Inc. 442
Testing effectiveness (Phase 2)Active Not RecruitingNCT06098326
What this trial is testing

CyFluATG in Lower Risk MDS

Who this might be right for
Myelodysplastic Syndromes
Asan Medical Center 30
Large-scale testing (Phase 3)Ended earlyNCT00486759
What this trial is testing

Bevacizumab (Avastin) in Combination With Rituximab (MabThera) and CHOP (Cyclophosphamide, Hydroxydaunorubicin [Doxorubicin], Oncovin [Vincristine], Prednisone) Chemotherapy in Patients With Diffuse Large B-cell Lymphoma

Who this might be right for
B-cell Lymphoma
Hoffmann-La Roche 787
Testing effectiveness (Phase 2)UnknownNCT04304352
What this trial is testing

Metronomic Oral Chemotherapy With Cyclophosphamide, Capecitabine and Vinorelbine in Metastatic Breast Cancer Patients

Who this might be right for
Advanced Breast Cancer
European Institute of Oncology 162
Early research (Phase 1)Study completedNCT01966289
What this trial is testing

SGI-110 in Combination With an Allogeneic Colon Cancer Cell Vaccine (GVAX) and Cyclophosphamide (CY) in Metastatic Colorectal Cancer (mCRC)

Who this might be right for
Metastatic Colorectal Cancer
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 18
Large-scale testing (Phase 3)Study completedNCT02256150
What this trial is testing

Evaluate the Efficacy and Safety of Mizoribine in the Treatment of Lupus Nephritis

Who this might be right for
Lupus Nephritis
Asahi Kasei Therapeutics Corporation 250
Large-scale testing (Phase 3)Looking for participantsNCT06615050
What this trial is testing

Tacrolimus/Methotrexate/Ruxolitinib Versus Post-Transplant Cyclophosphamide/Tacrolimus/Mycophenolate Mofetil in Non-Myeloablative/Reduced Intensity Conditioning Allogeneic Peripheral Blood Stem Cell Transplantation (BMT CTN 2203)

Who this might be right for
Graft-versus-host Disease (GVHD)
Incyte Corporation 572
Early research (Phase 1)Study completedNCT00001748
What this trial is testing

HLA-Mismatched Peripheral Blood Mobilized Hematopoietic Precursor Cell Transplantation for Hematological Malignancies

Who this might be right for
Graft vs Host DiseaseHematologic NeoplasmsLymphoma+2 more
National Heart, Lung, and Blood Institute (NHLBI) 35
Testing effectiveness (Phase 2)Ended earlyNCT01329640
What this trial is testing

Feasibility Study of Metronomic Chemotherapy for Locally Advanced Her2- Positive Breast Cancer (TraQ-Me 01)

Who this might be right for
Locally Advanced HER2-positive Breast Cancer
Instituto do Cancer do Estado de São Paulo 9
Large-scale testing (Phase 3)Active Not RecruitingNCT02567435
What this trial is testing

Combination Chemotherapy With or Without Temsirolimus in Treating Patients With Intermediate Risk Rhabdomyosarcoma

Who this might be right for
Alveolar RhabdomyosarcomaBotryoid-Type Embryonal RhabdomyosarcomaEmbryonal Rhabdomyosarcoma+3 more
National Cancer Institute (NCI) 325
Not applicableLooking for participantsNCT06790225
What this trial is testing

Glucose-dependent INsulinotropic Polypeptide: Effect on Bone Remodelling and Cell Activity (GINEBRA)

Who this might be right for
Bone Disease, MetabolicDiabetes Mellitus, Type 2Obesity and Obesity-related Medical Conditions
Esbjerg Hospital - University Hospital of Southern Denmark 12
Testing effectiveness (Phase 2)Study completedNCT02441803
What this trial is testing

Allogeneic Hematopoietic Stem Cell Transplantation (AlloSCT) Initial Salvage Therapy for Induction Failure Acute Myeloid Leukemia (AML)

Who this might be right for
Leukemia
M.D. Anderson Cancer Center 11
Testing effectiveness (Phase 2)Study completedNCT02413320
What this trial is testing

Neoadjuvant Study of Two Platinum Regimens in Triple Negative Breast Cancer

Who this might be right for
Triple-negative Breast Cancer
Priyanka Sharma 101
Testing effectiveness (Phase 2)Study completedNCT01610869
What this trial is testing

Low Dose Cyclophosphamide +/-- Nintedanib in Advanced Ovarian Cancer

Who this might be right for
Ovarian CancerFallopian Tube Cancer
University College, London 117
Testing effectiveness (Phase 2)Study completedNCT04224922
What this trial is testing

Phase II Study of Neoadjuvant Weekly Paclitaxel and Carboplatin Followed by Dose Dense Epirubicin and Cyclophosphamide in Stage II and III Triple Negative Breast Cancer

Who this might be right for
Breast Cancer
Universitair Ziekenhuis Brussel 63
Testing effectiveness (Phase 2)Study completedNCT00796562
What this trial is testing

Safety Study of Bone Marrow Transplant Using Mismatched Tissue Followed by Chemotherapy

Who this might be right for
MDSLeukemiasLymphomas
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 107
Testing effectiveness (Phase 2)Study completedNCT00499083
What this trial is testing

Paclitaxel, Cyclophosphamide & Doxorubicin, Autologous Dendritic Cells & Surgery in Stage II/III Breast Cancer (Women)

Who this might be right for
Breast Cancer
University of Nebraska 17
Next Page